276 followers
Cyberknife for recurrent Glioblastoma: median survival of 21 months, 7 months better compared to standard therapy. http://t.co/2Dymhm7H
Cyberknife for recurrent Glioblastoma: median survival of 21 months, 7 months better compared to standard therapy. http://t.co/2Dymhm7H